Rarer syndromes characterized by hypogonadotropic hypogonadism

Majid Aminzadeh, Hyung Goo Kim, Lawrence C. Layman, Timothy D. Cheetham

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hypogonadotropic hypogonadism (HH) secondary to hypothalamic gonadotropin-releasing hormone deficiency is a notable feature of a number of rare syndromes, where unlike idiopathic (isolated) HH, other endocrinopathies may also be apparent. The presence of a particular spectrum of clinical features in addition to HH may suggest a particular underlying diagnosis. Placing the diagnosis of HH into that context will then have important implications in terms of management and predicting long-term functional outcome. In some instances, establishing the genetic basis of a particular syndrome or disorder has advanced the understanding of normal hypothalamo-pituitary-gonadal function (e.g. LEP deficiency, DAX-1 and CHARGE syndrome) whilst in other disorders much has still to be learnt (e.g. Bardet-Biedl and Prader-Willi syndrome). In this chapter the above syndromes, where HH is a feature in most or all affected individuals, will be discussed. Recent advances in our understanding of the pathophysiology of the HH will be highlighted and management options presented. Longer term therapy with sex steroid replacement is becoming even more important if improvements in life expectancy are to be matched by improvements in quality of life.

Original languageEnglish (US)
Pages (from-to)154-167
Number of pages14
JournalFrontiers of Hormone Research
Volume39
DOIs
StatePublished - Apr 8 2010

Fingerprint

Hypogonadism
Gonadotropin-Releasing Hormone
Steroids
CHARGE Syndrome
Pituitary Hormone-Releasing Hormones
Prader-Willi Syndrome
Life Expectancy
Quality of Life

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Rarer syndromes characterized by hypogonadotropic hypogonadism. / Aminzadeh, Majid; Kim, Hyung Goo; Layman, Lawrence C.; Cheetham, Timothy D.

In: Frontiers of Hormone Research, Vol. 39, 08.04.2010, p. 154-167.

Research output: Contribution to journalArticle

Aminzadeh, Majid ; Kim, Hyung Goo ; Layman, Lawrence C. ; Cheetham, Timothy D. / Rarer syndromes characterized by hypogonadotropic hypogonadism. In: Frontiers of Hormone Research. 2010 ; Vol. 39. pp. 154-167.
@article{5fd773380b834304a0d7b13659bede39,
title = "Rarer syndromes characterized by hypogonadotropic hypogonadism",
abstract = "Hypogonadotropic hypogonadism (HH) secondary to hypothalamic gonadotropin-releasing hormone deficiency is a notable feature of a number of rare syndromes, where unlike idiopathic (isolated) HH, other endocrinopathies may also be apparent. The presence of a particular spectrum of clinical features in addition to HH may suggest a particular underlying diagnosis. Placing the diagnosis of HH into that context will then have important implications in terms of management and predicting long-term functional outcome. In some instances, establishing the genetic basis of a particular syndrome or disorder has advanced the understanding of normal hypothalamo-pituitary-gonadal function (e.g. LEP deficiency, DAX-1 and CHARGE syndrome) whilst in other disorders much has still to be learnt (e.g. Bardet-Biedl and Prader-Willi syndrome). In this chapter the above syndromes, where HH is a feature in most or all affected individuals, will be discussed. Recent advances in our understanding of the pathophysiology of the HH will be highlighted and management options presented. Longer term therapy with sex steroid replacement is becoming even more important if improvements in life expectancy are to be matched by improvements in quality of life.",
author = "Majid Aminzadeh and Kim, {Hyung Goo} and Layman, {Lawrence C.} and Cheetham, {Timothy D.}",
year = "2010",
month = "4",
day = "8",
doi = "10.1159/000312701",
language = "English (US)",
volume = "39",
pages = "154--167",
journal = "Frontiers of Hormone Research",
issn = "0301-3073",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Rarer syndromes characterized by hypogonadotropic hypogonadism

AU - Aminzadeh, Majid

AU - Kim, Hyung Goo

AU - Layman, Lawrence C.

AU - Cheetham, Timothy D.

PY - 2010/4/8

Y1 - 2010/4/8

N2 - Hypogonadotropic hypogonadism (HH) secondary to hypothalamic gonadotropin-releasing hormone deficiency is a notable feature of a number of rare syndromes, where unlike idiopathic (isolated) HH, other endocrinopathies may also be apparent. The presence of a particular spectrum of clinical features in addition to HH may suggest a particular underlying diagnosis. Placing the diagnosis of HH into that context will then have important implications in terms of management and predicting long-term functional outcome. In some instances, establishing the genetic basis of a particular syndrome or disorder has advanced the understanding of normal hypothalamo-pituitary-gonadal function (e.g. LEP deficiency, DAX-1 and CHARGE syndrome) whilst in other disorders much has still to be learnt (e.g. Bardet-Biedl and Prader-Willi syndrome). In this chapter the above syndromes, where HH is a feature in most or all affected individuals, will be discussed. Recent advances in our understanding of the pathophysiology of the HH will be highlighted and management options presented. Longer term therapy with sex steroid replacement is becoming even more important if improvements in life expectancy are to be matched by improvements in quality of life.

AB - Hypogonadotropic hypogonadism (HH) secondary to hypothalamic gonadotropin-releasing hormone deficiency is a notable feature of a number of rare syndromes, where unlike idiopathic (isolated) HH, other endocrinopathies may also be apparent. The presence of a particular spectrum of clinical features in addition to HH may suggest a particular underlying diagnosis. Placing the diagnosis of HH into that context will then have important implications in terms of management and predicting long-term functional outcome. In some instances, establishing the genetic basis of a particular syndrome or disorder has advanced the understanding of normal hypothalamo-pituitary-gonadal function (e.g. LEP deficiency, DAX-1 and CHARGE syndrome) whilst in other disorders much has still to be learnt (e.g. Bardet-Biedl and Prader-Willi syndrome). In this chapter the above syndromes, where HH is a feature in most or all affected individuals, will be discussed. Recent advances in our understanding of the pathophysiology of the HH will be highlighted and management options presented. Longer term therapy with sex steroid replacement is becoming even more important if improvements in life expectancy are to be matched by improvements in quality of life.

UR - http://www.scopus.com/inward/record.url?scp=84925955922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925955922&partnerID=8YFLogxK

U2 - 10.1159/000312701

DO - 10.1159/000312701

M3 - Article

C2 - 20389093

VL - 39

SP - 154

EP - 167

JO - Frontiers of Hormone Research

JF - Frontiers of Hormone Research

SN - 0301-3073

ER -